FDA warns against using surgical robots for breast cancer surgery

The FDA warned patients and health care providers Thursday about using robotically assisted surgical devices for mastectomies and other cancer surgeries because of "preliminary" evidence that it may be linked to lower long-term survival.

The FDA's official safety communication said that while robotic "surgery may help reduce pain, blood loss, scarring, infection, and recovery time," there is "limited, preliminary evidence" that using the devices for cancers that affect women, specifically breast and cervical cancer, may be associated with diminished long-term survival.

Read the full article HERE